Cédric Coulouarn, Bruno Clément  Journal of Hepatology 

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Global gene repression in hepatocellular carcinoma and fetal liver, and suppression of dudulin-2 mRNA as a possible marker for the cirrhosis-to-tumor transition.
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Pathological roles of purinergic signaling in the liver
Novel insights in the interplay between inflammation and metabolic diseases: A role for the pathogen sensing kinase PKR  Nicolas Marsollier, Pascal Ferré,
Anatoliy I. Masyuk, Tatyana V. Masyuk, Nicholas F. LaRusso 
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Obesity, inflammation, and liver cancer
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Immigration and viral hepatitis
Florie Borel, Pavlina Konstantinova, Peter L.M. Jansen 
Volume 61, Issue 3, Pages (September 2014)
Volume 66, Issue 1, Pages 1-4 (January 2017)
Living donor liver transplantation: is the hype over?
The origin of cancer stem cells
Mesenchymal stromal cell therapy for liver diseases
The place of downstaging for hepatocellular carcinoma
Biology of the immunomodulatory molecule HLA-G in human liver diseases
European Association for the Study of the Liver  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: Molecular networks and biological concepts  Chiara Raggi, Pietro Invernizzi,
Ariane Mallat, Sophie Lotersztajn  Journal of Hepatology 
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Genomic risk of hepatitis C-related hepatocellular carcinoma
Volume 43, Issue 4, Pages (October 2005)
Volume 59, Issue 3, Pages (September 2013)
EASL Clinical Practice Guidelines: Wilson’s disease
EASL Recognition Award Recipient 2017: Prof. Giorgina Mieli-Vergani
The changing role of beta-blocker therapy in patients with cirrhosis
Volume 57, Issue 5, Pages (November 2012)
Volume 50, Issue 4, Pages (April 2009)
Paul C. Adams, James C. Barton  Journal of Hepatology 
Volume 61, Issue 1, Pages S79-S90 (November 2014)
miR-122 – A key factor and therapeutic target in liver disease
Chetana Lim, Chady Salloum, Daniel Azoulay
Immigration and viral hepatitis
The potential of induced pluripotent stem cell derived hepatocytes
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
Global burden of alcoholic liver diseases
HCV targeting of patients with cirrhosis
Role of desmoplasia in cholangiocarcinoma and hepatocellular carcinoma
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
The use of hemospray in portal hypertensive bleeding; a case series
Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence  Christian Toso, Gilles Mentha, Pietro.
Tatiana Kisseleva, David A. Brenner  Journal of Hepatology 
Volume 65, Issue 4, Pages (October 2016)
Liver transplantation in children
Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi 
Volume 60, Issue 6, Pages (June 2014)
Pathogenesis of cholestatic hepatitis C
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing  Roongruedee Chaiteerakij,
Chimeric mouse model of hepatitis B virus infection
A 360-degree overview of paediatric NAFLD: Recent insights
Genetics of hepatocellular carcinoma: The next generation
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Volume 60, Issue 6, Pages (June 2014)
Presentation transcript:

Stellate cells and the development of liver cancer: Therapeutic potential of targeting the stroma  Cédric Coulouarn, Bruno Clément  Journal of Hepatology  Volume 60, Issue 6, Pages 1306-1309 (June 2014) DOI: 10.1016/j.jhep.2014.02.003 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Therapeutic potential of targeting HSC and the stroma in liver cancer. Depicted is the interplay between tumors cells and components of the microenvironment, notably HSC, which influence tumor progression by creating a permissive environment and by perverting the phenotype of tumor cells. Each of these interactions, symbolized by arrows, could be targeted for therapeutic purpose. Epigenetic modulation of the crosstalk between tumor cells and their microenvironment may also open new therapeutic opportunities in liver cancers. Journal of Hepatology 2014 60, 1306-1309DOI: (10.1016/j.jhep.2014.02.003) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2014 60, 1306-1309DOI: (10. 1016/j. jhep. 2014 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions